Literature DB >> 15883308

The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2.

H H Klünemann1, B H Ridha, L Magy, J R Wherrett, D M Hemelsoet, R W Keen, J L De Bleecker, M N Rossor, J Marienhagen, H E Klein, L Peltonen, J Paloneva.   

Abstract

BACKGROUND: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), or Nasu-Hakola disease, is a presenile dementia associated with loss of myelin, basal ganglia calcification, and bone cysts. It is caused by recessively inherited mutations in two genes encoding subunits of a cell membrane-associated receptor complex: TREM2 and DAP12. The clinical course of PLOSL has not been characterized in a series of patients with TREM2 mutations.
METHODS: The authors compare neurologic and neuroradiologic follow-up data of six patients carrying TREM2 mutations with PLOSL due to defective DAP12 genes. The authors review the known mutations in these two genes.
RESULTS: Mutations in DAP12 and TREM2 result in a uniform disease phenotype. In Finnish and Japanese patients with PLOSL, DAP12 mutations predominate, whereas TREM2 is mutated more frequently elsewhere.
CONCLUSIONS: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy should be considered in adult patients under age 50 years with dementia and basal ganglia calcification. Radiographs of ankles and wrists, and DNA test in uncertain cases, confirm the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883308     DOI: 10.1212/01.WNL.0000160304.00003.CA

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  87 in total

Review 1.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration.

Authors:  Marco Prinz; Josef Priller; Sangram S Sisodia; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2011-09-27       Impact factor: 24.884

Review 2.  The myeloid cells of the central nervous system parenchyma.

Authors:  Richard M Ransohoff; Astrid E Cardona
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.

Authors:  Laura Piccio; Yuetiva Deming; Jorge L Del-Águila; Laura Ghezzi; David M Holtzman; Anne M Fagan; Chiara Fenoglio; Daniela Galimberti; Barbara Borroni; Carlos Cruchaga
Journal:  Acta Neuropathol       Date:  2016-01-11       Impact factor: 17.088

Review 4.  TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.

Authors:  Marco Colonna; Yaming Wang
Journal:  Nat Rev Neurosci       Date:  2016-02-25       Impact factor: 34.870

5.  Diagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.

Authors:  T Konno; D F Broderick; N Mezaki; A Isami; D Kaneda; Y Tashiro; T Tokutake; B M Keegan; B K Woodruff; T Miura; H Nozaki; M Nishizawa; O Onodera; Z K Wszolek; T Ikeuchi
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-15       Impact factor: 3.825

6.  CSF-1R, DAP12 and beta-catenin: a ménage à trois.

Authors:  Daniel W McVicar; Giorgio Trinchieri
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

7.  Genetic Analysis of TREM2 Variants in Tunisian Patients with Alzheimer's Disease.

Authors:  Zied Landoulsi; Mouna Ben Djebara; Imen Kacem; Youssef Sidhom; Rym Kefi; Sonia Abdelhak; Amina Gargouri-Berrechid; Riadh Gouider
Journal:  Med Princ Pract       Date:  2018-05-03       Impact factor: 1.927

8.  Alzheimer's disease pathology in Nasu-Hakola disease brains.

Authors:  Jun-Ichi Satoh; Yoshihiro Kino; Motoaki Yanaizu; Yuko Saito
Journal:  Intractable Rare Dis Res       Date:  2018-02

Review 9.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

10.  Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Margarita Giraldo; Francisco Lopera; Ashley L Siniard; Jason J Corneveaux; Isabelle Schrauwen; Julian Carvajal; Claudia Muñoz; Manuel Ramirez-Restrepo; Chris Gaiteri; Amanda J Myers; Richard J Caselli; Kenneth S Kosik; Eric M Reiman; Matthew J Huentelman
Journal:  Neurobiol Aging       Date:  2013-04-09       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.